Pregled bibliografske jedinice broj: 193597
The development of PL 14736 for treatment of inflammatory bowel disease
The development of PL 14736 for treatment of inflammatory bowel disease // Abstract book of the 3rd Congress of the Croatian Society of gastroenterology
Zagreb, 2001. str. 9-9 (poster, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 193597 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The development of PL 14736 for treatment of inflammatory bowel disease
Autori
Veljača, Marija ; Krnić, Žarka ; Brajša, Karmen ; Pavić-Sladoljev, Dubravka ; Mildner, Boris ; Ševeljević-Jaran, Daša ; Kolega, Marko ; Erceg, Damir ; Krznarić, Željko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstract book of the 3rd Congress of the Croatian Society of gastroenterology
/ - Zagreb, 2001, 9-9
Skup
Congress of the Croatian Society of gastroenterology (3 ; 2001)
Mjesto i datum
Zagreb, Hrvatska, 23.09.2001. - 26.09.2001
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
IBD; peptide non-clinical safety
Sažetak
Pl 14736 is a 15 amino acid peptide of a unique sequence, a part of a larger molecule. Pharmacological activity of PL 14 736 has been tested in vitro and in vivo, revealing beneficial activity against experimental tissue damage. Since PL 14736 has shown potent protective and healing properties in the models of upper gastrointestinal tract lesions and in particular in acute and sub-acute models of colitis, this compound was taken to pursue pre-clinical development for IBD indication. In order to fulfill regulatory requirements for the conduct of the phase I study, all non-clinical safety studies were performed with PL 14736.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Profili:
Željko Krznarić
(autor)
Žarka Krnić
(autor)
Karmen Brajša
(autor)
Damir Erceg
(autor)
Boris Mildner
(autor)
Marko Kolega
(autor)